Relationship between the Size of Magnetic Nanoparticles and Efficiency of MRT Imaging of Cerebral Glioma in Rats
- Autores: Semkina A.S.1, Abakumov M.A.1, Abakumov A.M.2, Nukolova N.V.3, Chekhonin V.P.1,3
- 
							Afiliações: 
							- Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University
- Electron Microscopy for Materials Science (EMAT), University of Antwerp
- V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation
 
- Edição: Volume 161, Nº 2 (2016)
- Páginas: 292-295
- Seção: Biotechnologies
- URL: https://journals.rcsi.science/0007-4888/article/view/237346
- DOI: https://doi.org/10.1007/s10517-016-3398-y
- ID: 237346
Citar
Resumo
BSA-coated Fe3O4 nanoparticles with different hydrodynamic diameters (36±4 and 85±10 nm) were synthesized, zeta potential and T2 relaxivity were determined, and their morphology was studied by transmission electron microscopy. Studies on rats with experimental glioma C6 showed that smaller nanoparticles more effectively accumulated in the tumor and circulated longer in brain vessels. Optimization of the hydrodynamic diameter improves the efficiency of MRT contrast agent.
Sobre autores
A. Semkina
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University
							Autor responsável pela correspondência
							Email: alevtina.semkina@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
M. Abakumov
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
A. Abakumov
Electron Microscopy for Materials Science (EMAT), University of Antwerp
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Bélgica, 							Groenenborgerlaan, Antwerp						
N. Nukolova
V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
V. Chekhonin
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University; V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Rússia, 							Moscow; Moscow						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					